GT
Healthcare & Life Sciences
Galvanize Therapeutics
Galvanize Therapeutics is a Healthcare & Life Sciences startup, most recent round Series C, 1 tracked investor.
Activeseries-c
series-c
Stage
1
Investors
About Galvanize Therapeutics
Galvanize Therapeutics is a startup. Its most recent tracked round is Series C. Brouky classifies it under Healthcare & Life Sciences. Brouky records 1 investor associated with the company.
Develops the Aliya® pulsed electric field (PEF) ablation system, a medical device designed to treat cancer and chronic lung disease, with clinical trials focused on late-stage non-small cell lung cancer and lung metastases.
Explore Galvanize Therapeutics's full profile on Brouky
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.